BM86 Immunomodulator Vials

Closed Solicitation Posted

Solicitation number
12639526Q0079
Agency
Marketing and Regulatory Programs Business Services Animal and Plant Health Inspection Service, Department of Agriculture
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
Laredo, Texas 78041, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The United States Department of Agriculture Animal and Plant Health Inspection Service (USDA APHIS) is soliciting quotations for 1,400 units of BM86 Immunomodulator 10DS 20ML vials, an experimental veterinary biological product used for the treatment of cattle fever ticks under the Cattle Fever Tick Eradication Program in Texas. This is a sole-source procurement issued as Request for Quotation (RFQ) number 12639526Q0079 under FAR Part 12 for commercial items, meaning this announcement serves as the only solicitation and no separate written solicitation will be issued. Quotations must be submitted by March 27, 2026, at 5:00 PM ET, with technical approach, price reasonableness, and past performance serving as the three evaluation criteria; award will be made to the highest technically rated offeror provided the price is fair and reasonable and past performance is acceptable or neutral. Offerors must submit questions via email to Kathy.Melby@usda.gov by March 26, 2026, at 3:00 PM ET, and all offers must include pricing for all items to be considered responsive, with prices held firm for 90 calendar days from the offer due date.

This acquisition is not set-aside for small business concerns and represents an unrestricted requirement open to all responsible sources, though Zoetis Inc. is identified as the intended source due to its exclusive property rights to the BM86 product with no alternatives available to meet USDA requirements. The contract will be awarded as a firm-fixed price purchase order with one award anticipated and delivery required by September 1, 2026, to accommodate the vendor's mandatory six-month production lead time for ingredient assembly, vaccine production and blending, and quality control testing. Delivery is F.O.B. Destination to the USDA APHIS VS Cattle Tick Fever Office in Laredo, Texas 78041. The solicitation incorporates FAR and AGAR clauses including Buy American provisions, electronic funds transfer payment requirements, and anti-discrimination and diversity, equity, and inclusion compliance requirements. Protests may be filed through USDA's Ombudsman Program for Agency Protests (OPAP).

Notice text

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR Part 12.  This announcement constitutes the only solicitation.  Quotations are being requested and a separate written solicitation will not be issued. 

The intended source for this acquisition is Zoetis Inc.

The proposed contractor, Zoetis Inc. has exclusive property rights to this product and no alternatives are available to meet USDA requirements.

Solicitation number 12639526Q0079 is issued as a Request for Quotation (RFQ) for 1,400 BM86 Immunomodulator 10DS 20ML Vials  

This acquisition  is not set-aside for small business concerns.  The applicable North American Industry Classification Standard Code is 325412  The small business size standard is 1,300 employees  This acquisition is an unrestricted requirement.   All responsible sources may submit a quotation which will be considered by the agency. 

Attachments

Files attached to this notice, newest first
File Type Posted
Sole Source Justification - BM86 Immunomodulator Vials.pdf PDF
12639526Q0079.pdf PDF

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity